Microbiology
Specimens
5 samples simulating plasma, 1.5 mL
Examinations
CMV and EBV NAT (quantitative).
Important Notes
Quantitative result processing.
Immunology
Specimens
2 plasma or serum samples, 0.7 mL
Examinations
Endomysium antibodies, tissue transglutaminase antibodies, deamidated gliadin peptide antibodies, interpretation of the Total IgA concentration of the sample. Pre- and/or post-analytical cases in part of the rounds.
Important Notes
Quantitative results are also processed (tTGAbA, tTGAbG, DGPAbA, DGPAbG). Scheme is not suitable for POCT.
Haematology
Specimens
3-5 cases and digital images (DiaMed and Grifols cards).
Examinations
Interpretation of the cases and reaction strengths of the digital images.
Important Notes
Post-analytical scheme for blood transfusion procedures.
Clinical Chemistry
Specimens
1 Human serum sample, 1 mL.
Examinations
CRP.
Important Notes
CRP, low concentration sample is included in product 2541 Myocardiac markers and CRP.
Microbiology
Specimens
2 liquid samples.
Examinations
Chemokine CXCL13 detection.
Important Notes
Clinical Chemistry
Specimens
2 human plasma samples with reference target values, 0.75 mL.
Examinations
P-Cystatin C, P-Creatinine, P-eGFR.
Important Notes
Two rounds per year. Organised in co-operation with DEKS. Participation in all rounds is required. Register orders before the end of December.
Microbiology
Specimens
3 plasma samples, 0.7 mL.
Examinations
Cytomegalovirus IgG, IgM and total antibodies, IgG avidity and post-analytical clinical interpretation.
Important Notes
Haematology
Specimens
2 liquid commercial plasma samples, 0.5 mL.
Examinations
D-Dimer.
Important Notes
For clinical laboratories and POCT sites. D-dimer testing for thrombosis assessment.
Haematology
Specimens
2 liquid commercial plasma samples, 0.5 mL.
Examinations
D-Dimer.
Important Notes
Only in connection with scheme 4388.
Microbiology
Specimens
3 plasma samples, 0.5 mL.
Examinations
Dengue virus IgG and IgM antibodies, Dengue virus antigen (NS1) and post-analytical clinical interpretation.
Important Notes
For clinical laboratories and POCT sites.
Others
Specimens
Two samples (amplicons) and two primer pairs for a total of 4 sequence reactions are distributed to the participants.
Examinations
Both ability to identify the sequence and report according to HGVS nomenclature are assessed.
Important Notes
One round per year.
Organised in co-operation with EQUALIS. Participation in all rounds is required. Register orders before the end of December.
Others
Specimens
Whole blood or extracted DNA. Blank samples (water) are sometimes included.
Examinations
DNA-Apolipoprotein E genotype, DNA-Factor 2 (F2) g.20210G>A, DNA-Factor 5 (F5) c.1691G>A, DNA-Hemochromatosis (HFE) c.187C>G; c.845G>A, DNA-Lactase gene (LCT) g.13910C>T, DNA-Methylene tetrahydropholate reductase (MTHFR) c.677C>T; c.1298A>Cx.
Important Notes
Two rounds per year.
Organised in co-operation with EQUALIS. Participation in all rounds is required. Register orders before the end of December.